Xin Sun Wenjuan Chen Xiujuan Qu Ying Chen
10.3389/fphar.2022.968060
Front Pharmacol
2022 Aug 12;13:968060.
brca2 germline mutation parpi case report cutaneous squamous cell carcinoma fluzoparib
CC BY
https://pubmed.ncbi.nlm.nih.gov/36034850/
Case Reports
PMC9411933
36034850
Case Report: Fluzoparib for multiple lines of chemotherapy refractory in metastatic cutaneous squamous cell carcinoma with BRCA2 pathogenic mutation
2022